Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cephalo Ventures is a venture capital organization founded to support scientific research and innovation, operating in both the United States and the United Kingdom. The firm focuses on early-stage biotech startups, particularly in therapeutics, synthetic biology, and medical devices, with a portfolio of four companies. They provide funding ranging from $150,000 to $300,000.
Cephalo Ventures invests in early-stage biotech startups at the pre-seed to Series A stages, offering funding between $150,000 and $300,000. Their investment thesis emphasizes scientific advancements that can positively impact society, particularly in therapeutics, synthetic biology, and medical devices. The firm also runs the Transferase Accelerator program, which includes workshops and access to a network of biotech investors.
Notable portfolio companies include Boston Bioprocess, Oxford SimCell, RiverWalk Therapeutics, and Imaginostics.
Submit your pitch through their form at https://cephalo.ventures.
Cephalo Ventures runs the Transferase Accelerator, which offers workshops and access to a network of biotech investors to support fundraising efforts for startups.
Cephalo Ventures typically participates in early-stage funding rounds, often leading investments in the pre-seed to Series A stages.
The firm is open to follow-on investments, particularly for startups that demonstrate significant progress and potential for societal impact.
Specific details about the fund size are not disclosed, but they focus on investments ranging from $150,000 to $300,000 in early-stage biotech companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.